References
1. Cooper J, Mancuso SG, Borland R, Slade T, Galletly C, et al. Tobacco smoking among people living with a psychotic illness: The second Australian survey of psychosis. Australian and New Zealand Journal of Psychiatry, 2012; 46(9):851–63. Available from: http://anp.sagepub.com/content/46/9/851.abstract
2. Williams JM, Steinberg ML, Griffiths KG, and Cooperman N. The need for smokers with behavioral health comorbidity to be designated as a tobacco use disparity group. American Journal of Public Health, 2013; 103(9):1549–55. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776478/
3. Forman-Hoffman VL, Hedden SL, Glasheen C, Davies C, and Colpe LJ. The role of mental illness on cigarette dependence and successful quitting in a nationally representative, household-based sample of US adults. Annals of Epidemiology, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27247163
4. Lawrence D, Hancock KJ, and Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: Retrospective analysis of population based registers. British Medical Journal, 2013; 346. Available from: http://www.bmj.com/bmj/346/bmj.f2539.full.pdf
5. Tam J, Warner KE, and Meza R. Smoking and the reduced life expectancy of individuals with serious mental illness. American Journal of Preventive Medicine, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27522471
6. Minichino A, Bersani FS, Calo WK, Spagnoli F, Francesconi M, et al. Smoking behaviour and mental health disorders--mutual influences and implications for therapy. International Journal of Environmental Research and Public Health, 2013; 10(10):4790–811. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24157506
7. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, et al. Change in mental health after smoking cessation: Systematic review and meta-analysis. British Medical Journal, 2014; 348:g1151. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24524926
8. Mendelsohn CP, Kirby DP, and Castle DJ. Smoking and mental illness. An update for psychiatrists. Australas Psychiatry, 2015; 23(1):37–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25512967
9. Prochaska JJ. Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug and Alcohol Dependence, 2010; 110(3):177–82. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916693/
10.Australian Institute of Health and Welfare. Data tables: National Drug Strategy Household Survey 2019 - 2. Tobacco smoking chapter, supplementary data tables. Canberra: AIHW, 2020. Available from: https://www.aihw.gov.au/reports/illicit-use-of-drugs/national-drug-strategy-household-survey-2019/data
11. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, et al. People living with psychotic illness: An Australian study 1997−98. Mental Health Branch, Commonwealth Department of Health and Aged Care.Canberra 1999.
12. Australian Institute for Health and Welfare, National Drug Strategy Household Survey, 2016 [computer file]. Canberra: Australian Data Archive, The Australian National University; 2017.
13. Australian Bureau of Statistics. TableBuilder. Available from: http://www.abs.gov.au/websitedbs/d3310114.nsf/home/about+tablebuilder
14. Australian Bureau of Statistics. 4364.0.55.001–National Health Survey: First results, 2014–15 Available from: http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/4364.0.55.001~2014-15~Main%20Features~Key%20findings~1
15. Smith PH, Mazure CM, and McKee SA. Smoking and mental illness in the US population. Tobacco Control, 2014; 23(e2):e147–53. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24727731
16. Ziedonis D, Hitsman B, Beckham J, Zvolensky M, Adler L, et al. Tobacco use and cessation in psychiatric disorders: National institute of mental health report. Nicotine & Tobacco Research, 2008; 10(12):1691–715. Available from: http://www.informaworld.com/smpp/content~db=all?content=10.1080/14622200802443569
17. Sung H, Prochaska J, Ong M, Shi Y, and Max W. Cigarette smoking and serious psychological distress: A population-based study of California adults. Nicotine & Tobacco Research, 2011; 13(12):1183–92. Available from: http://ntr.oxfordjournals.org/content/early/2011/08/17/ntr.ntr148.full
18. Lasser K, Boyd L, Woolhandler S, Himmelstein S, McCormick D, et al. Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association, 2000; 284(2):2606–10. Available from: http://jama.ama-assn.org/cgi/content/full/284/20/2606
19. Grant BF, Hasin DS, Chou SP, Stinson FS, and Dawson DA. Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 2004; 61(11):1107–15. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/15520358
20. Public Health England, Smoking cessation in secure mental health settings. London 2015. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/432222/Smoking_Cessation_in_Secure_Mental_Health_Settings_-_guidance_for_commis....pdf .
21. de Leon J and Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 2005; 76(2–3):135–57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15949648
22. Dehay T, Morris C, May M, Devine K, and Waxmonsky J. Tobacco use in youth with mental illnesses. Journal of Behavioral Medicine, 2012; 35(2):139–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21479646
23. Kollins SH, McClernon F, and Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Archives of General Psychiatry, 2005; 62(10):1142–47. Available from: http://dx.doi.org/10.1001/archpsyc.62.10.1142
24. Australian Institute of Health and Welfare. National Drug Strategy Household Survey detailed report: 2013. Cat. no. PHE 183 Canberra: AIHW, 2014. Available from: http://www.aihw.gov.au/publication-detail/?id=60129549469&tab=3 .
25. Ashton M, Miller C, Bowden J, and Bertossa S. People with mental illness can tackle tobacco. The Australian and New Zealand Journal of Psychiatry, 2010; 44(11):1021–8. Available from: http://informahealthcare.com/doi/pdf/10.3109/00048674.2010.497753
26. Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, et al. Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Research, 2007; 150(2):141–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17289155
27. Williams J and Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 2004; 29(6):1067–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15236808
28. Williams J, Gandhi K, Lu S, Kumar S, Steinberg M, et al. Shorter interpuff interval is associated with higher nicotine intake in smokers with schizophrenia. Drug and Alcohol Dependence, 2011; 118(2–3):313–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21596491
29. Khaled S, Bulloch A, Williams J, Lavorato D, and Patten S. Major depression is a risk factor for shorter time to first cigarette irrespective of the number of cigarettes smoked per day: Evidence from a national population health survey. Nicotine & Tobacco Research, 2011; 13(11):1059–67. Available from: http://ntr.oxfordjournals.org/content/early/2011/08/10/ntr.ntr157.full
30. Lawrence D and Williams JM. Trends in smoking rates by level of psychological distress-time series analysis of US national health interview survey data 1997-2014. Nicotine & Tobacco Research, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26705303
31. Steinberg ML, Williams JM, and Li Y. Poor mental health and reduced decline in smoking prevalence. American Journal of Preventive Medicine, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26071864
32. Weinberger AH, Gbedemah M, Wall MM, Hasin DS, Zvolensky MJ, et al. Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: Emerging disparities in vulnerable populations. Addiction, 2017. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29265574
33. Dickerson F, Schroeder J, Katsafanas E, Khushalani S, Origoni AE, et al. Cigarette smoking by patients with serious mental illness, 1999-2016: An increasing disparity. Psychiatric Services, 2017:appips201700118. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28945183
34. Zvolensky MJ, Jardin C, Wall MM, Gbedemah M, Hasin D, et al. Psychological distress among smokers in the United States: 2008 to 2014. Nicotine & Tobacco Research, 2017. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28482108
35. Kulik MC and Glantz SA. Softening among u.S. Smokers with psychological distress: More quit attempts and lower consumption as smoking drops. American Journal of Preventive Medicine, 2017. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29029966
36. Weinberger AH, Gbedemah M, and Goodwin RD. Cigarette smoking quit rates among adults with and without alcohol use disorders and heavy alcohol use, 2002-2015: A representative sample of the United States population. Drug and Alcohol Dependence, 2017; 180:204–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28918239
37. Australian Bureau of Statistics. 4364.0.55.001 - Australian Health Survey: First Results, 2011–12, 2012. Available from: http://www.abs.gov.au/ausstats/abs@.nsf/lookup/4364.0.55.001main+features12011-12
38. Ragg M and Ahmed T, Smoke and mirrors: A review of the literature on smoking and mental illness. Tackiling tobacco program research series no 1 Sydney: Cancer Council NSW; 2008. Available from: http://www.cancerdirectory.com.au/resource/view?slug=Smoke-and-Mirrors-A-review-of-the-literature-on-smoking-and-mental-illness&page=1 .
39. Hall S and Prochaska J. Treatment of smokers with co-occurring disorders: Emphasis on integration in mental health and addiction treatment settings. Annual Review of Clinical Psychology, 2009; 5:409–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19327035
40. Lawn S and Pols R. Nicotine withdrawal: Pathway to aggression and assault in the locked psychiatric ward? Australasian Psychiatry, 2003; 11(2):199–203. Available from: http://apy.sagepub.com/content/11/2/199.abstract
41. Olivier D, Lubman D, and Fraser R. Tobacco smoking within psychiatric inpatient settings: Biopsychosocial perspective. Australia and New Zealand Journal of Psychiatry, 2007; 41(7):572–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17558619
42. Dwyer T, Bradshaw J, and Happell B. Comparison of mental health nurses' attitudes towards smoking and smoking behaviour. International Journal of Mental Health Nursing, 2009; 18(6):424–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19883414
43. Aubin H-J, Rollema H, Svensson TH, and Winterer G. Smoking, quitting, and psychiatric disease: A review. Neuroscience & Biobehavioral Reviews, 2012; 36(1):271–84. Available from: http://www.sciencedirect.com/science/article/pii/S0149763411001175
44. Reilly P, Murphy L, and Alderton D. Challenging the smoking culture within a mental health service supportively. International Journal of Mental Health Nursing, 2006; 15(4):272–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17064324
45. Peckham E, Bradshaw TJ, Brabyn S, Knowles S, and Gilbody S. Exploring why people with SMI smoke and why they may want to quit: Baseline data from the SCIMITAR RCT. Journal of Psychiatric and Mental Health Nursing, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26147943
46. Trainor K and Leavey G. Barriers and facilitators to smoking cessation among people with severe mental illness: A critical appraisal of qualitative studies. Nicotine & Tobacco Research, 2016. Available from: http://ntr.oxfordjournals.org/content/early/2016/08/11/ntr.ntw183.abstract
47. Morisano D, Bacher I, Audrain-McGovern J, and George T. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Canadian Journal of Psychiatry, 2009; 54(6):356–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19527556
48. Manzella F, Maloney SE, and Taylor GT. Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World Journal of Psychiatry, 2015; 5(1):35–46. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369547/
49. Boggs DL, Surti TS, Esterlis I, Pittman B, Cosgrove K, et al. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia. Schizophrenia Research, 2017. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28392208
50. Kassel JD, Stroud L, and Paronis C. Smoking, stress and negative affect: Correlation, causation and context across stages of smoking. Psychological Bulletin, 2003; 192(2):270–304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12696841
51. Poorolajal J and Darvishi N. Smoking and suicide: A meta-analysis. PLoS ONE, 2016; 11(7):e0156348. Available from: http://dx.doi.org/10.1371%2Fjournal.pone.0156348
52. Yaworski D, Robinson J, Sareen J, and Bolton JM. The relation between nicotine dependence and suicide attempts in the general population. Canadian Journal of Psychiatry, 2011; 56(3):161–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21443823
53. Sankaranarayanan A and Castle D. Burden associated with smoking as a suicidal risk factor in an Australian sample of patients with psychosis. Australas Psychiatry, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27130725
54. Sankaranarayanan A, Clark V, Baker A, Palazzi K, Lewin TJ, et al. Reducing smoking reduces suicidality among individuals with psychosis: Complementary outcomes from a healthy lifestyles intervention study. Psychiatry Res, 2016; 243:407–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27450743
55. Gurillo P, Jauhar S, Murray RM, and MacCabe JH. Does tobacco use cause psychosis? Systematic review and meta-analysis. The Lancet Psychiatry, 2015; 2(8):718–25. Available from: http://dx.doi.org/10.1016/S2215-0366(15)00152-2
56. Prochaska J. Smoking and mental illness--breaking the link. The New England Journal of Medicine, 2011; 365(3):196–8. Available from: http://www.nejm.org/doi/full/10.1056/NEJMp1105248
57. Tidey JW and Miller ME. Smoking cessation and reduction in people with chronic mental illness. British Medical Journal, 2015; 351:h4065. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26391240
58. Jenkins R, Bhugra D, Bebbington P, Brugha T, Farrell M, et al. Debt, income and mental disorder in the general population. Psychological Medicine, 2008; 38(10):1485–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18184442
59. Department of Health, National mental health report. Australian Government; 2013. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/mental-pubs-n-report13 .
60. Lawn S, Hersh D, Ward P, Tsourtos G, Muller R, et al. 'I just saw it as something that would pull you down, rather than lift you up': Resilience in never-smokers with mental illness. Health Education Research, 2011; 26(1):26–38. Available from: http://her.oxfordjournals.org/content/early/2010/11/09/her.cyq065.full.pdf
61. Twyman L, Bonevski B, Paul C, and Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: A systematic review of the qualitative and quantitative literature. BMJ Open, 2014; 4(12):e006414. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25534212
62. Lawn S. Systematic barriers to quitting smoking among institutionalised public mental health service populations: A comparison of two Australian sites. The International Journal of Social Psychiatry, 2004; 50(3):201–15. Available from: http://isp.sagepub.com/cgi/content/abstract/50/3/204
63. Sundgren E, Hallqvist J, and Fredriksson L. Health for smokers with schizophrenia - a struggle to maintain a dignified life. Disability and Rehabilitation, 2015:1–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25958996
64. Ragg M, Gordon R, Ahmed T, and Allan J. The impact of smoking cessation on schizophrenia and major depression. Australasian Psychiatry, 2013; 21(3):238–45. Available from: http://apy.sagepub.com/content/21/3/238.abstract
65. Banham L and Gilbody S. Smoking cessation in severe mental illness: What works? Addiction, 2010; 105(7):1176–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20491721
66. Bolam B, West R, and Gunnell D. Does smoking cessation cause depression and anxiety? Findings from the attempt cohort. Nicotine & Tobacco Research, 2011; 13(3):209–14. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21330275
67. Prochaska JJ, Delucchi K, and Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of Consulting and Clinical Psychology, 2004; 72(6):1144–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15612860
68. Winhusen TM, Somoza EC, Brigham GS, Liu DS, Green CA, et al. Does treatment of attention deficit hyperactivity disorder (ADHD) enhance response to smoking cessation intervention in ADHD smokers? A randomized trial. The Journal of Clinical Psychiatry, 2010; 71(12):1680–8. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151610/
69. Covey LS, Hu M-C, Winhusen T, Weissman J, Berlin I, et al. Oros-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences. Drug and Alcohol Dependence, 2010; 110(1-2):156–9. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913299/
70. Covey LS, Hu MC, Winhusen T, Lima J, Berlin I, et al. Anxiety and depressed mood decline following smoking abstinence in adult smokers with attention deficit hyperactivity disorder. Journal of Substance Abuse Treatment, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26272693
71. Hitsman B, Borrelli B, McChargue DE, Spring B, and Niaura R. History of depression and smoking cessation outcome: A meta-analysis. Journal of Consulting and Clinical Psychology, 2003; 71(4):657–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12924670
72. Siru R, Hulse GK, and Tait RJ. Assessing motivation to quit smoking in people with mental illness: A review. Addiction, 2009; 104(5):719–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19413788
73. Brown CH, Medoff D, Dickerson FB, Fang LJ, Lucksted A, et al. Factors influencing implementation of smoking cessation treatment within community mental health centers. Journal of Dual Diagnosis, 2015; 11(2):145–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25985201
74. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, et al. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. Journal of the American Medical Association, 2014; 311(2):172–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24399556
75. Tidey JW, Colby SM, and Xavier EM. Effects of smoking abstinence on cigarette craving, nicotine withdrawal, and nicotine reinforcement in smokers with and without schizophrenia. Nicotine & Tobacco Research, 2014; 16(3):326–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24113929
76. Anzai N, Young-Wolff KC, and Prochaska JJ. Symptom severity and readiness to quit among hospitalized smokers with mental illness. Psychiatric Services, 2015; 66(4):443–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25828988
77. McNeill A. Smoking and mental health: A review of the literature. London: Smokefree London Programme, 2001. Available from: http://www.ash.org.uk/html/policy/menlitrev.pdf
78. Morris CD, Burns EK, Waxmonsky JA, and Levinson AH. Smoking cessation behaviors among persons with psychiatric diagnoses: Results from a population-level state survey. Drug and Alcohol Dependence, 2014; 136:63–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24417963
79. Siru R, Hulse G, Khan R, and Tait R. Motivation to quit smoking among hospitalised individuals with and without mental health disorders. The Australian and New Zealand Journal of Psychiatry, 2010; 44(7):640–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20560851
80. Moeller-Saxone K. Cigarette smoking and interest in quitting among consumers at a psychiatric disability rehabilitation and support service in Victoria. Australian and New Zealand Journal of Public Health, 2008; 32(5):479–81. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1753-6405.2008.00283.x/abstract
81. Young-Wolff KC, Fromont SC, Delucchi K, Hall SE, Hall SM, et al. PTSD symptomatology and readiness to quit smoking among women with serious mental illness. Addictive Behaviors, 2014; 39(8):1231–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24813548
82. Dickerson F, Bennett M, Dixon L, Burke E, Vaughan C, et al. Smoking cessation in persons with serious mental illnesses: The experience of successful quitters. Psychiatric Rehabilitation Journal, 2011; 34(4):311–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21459747
83. Hitsman B, Moss T, Montoya I, and George T. Treatment of tobacco dependence in mental health and addictive disorders. Canadian Journal of Psychiatry, 2009; 54(6):368–78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19527557
84. Cavazos-Rehg PA, Breslau N, Hatsukami D, Krauss MJ, Spitznagel EL, et al. Smoking cessation is associated with lower rates of mood/anxiety and alcohol use disorders. Psychological Medicine, 2014; 44(12):2523–35. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25055171
85. The Royal Australian College of General Practitioners, Supporting smoking cessation: A guide for health professionals. Melbourne: RACGP; 2014. Available from: http://www.racgp.org.au/your-practice/guidelines/smoking-cessation/ .
86. Patnode CD, Henderson JT, Thompson JH, Senger CA, Fortmann SP, et al. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: A review of reviews for the US Preventive Services Task Force. Annals of Internal Medicine, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26389650
87. Oliveira P, Ribeiro J, Donato H, and Madeira N. Smoking and antidepressants pharmacokinetics: A systematic review. Annals of General Psychiatry, 2017; 16:17. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28286537
88. Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): A double-blind, randomised, placebo-controlled clinical trial. Lancet, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27116918
89. Stockings EA, Bowman JA, Baker AL, Terry M, Clancy R, et al. Impact of a postdischarge smoking cessation intervention for smokers admitted to an inpatient psychiatric facility: A randomized controlled trial. Nicotine & Tobacco Research, 2014; 16(11):1417–28. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24939916
90. SANE Australia. Smoking cessation in long term psychiatric patients. Melbourne: SANE Australia.
91. Quit South Australia, The Tobacco and Mental Illness Project, and The Queen Elizabeth Hospital and Health Service, 'I’m giving it a go'. A step-by-step guide for people with mental illness who smoke and want to cut down or quit. Adelaide, SA: Quit South Australia; 2004.
92. Bertossa S. You can do it! A positive approach to supporting people to address tobacco. The Mental Health Services Conference, Sydney, 2005.
93. Quit Group. Minimum standards for Australian quitline services, 2007.
94. van der Meer RM, Willemsen MC, Smit F, and Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database of Systematic Reviews, 2013; 8:Cd006102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23963776
95. Weinberger AH, Pilver CE, Desai RA, Mazure CM, and McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: Longitudinal evaluation in the US population. Addiction, 2012; 107(10):1847–56. Available from: http://dx.doi.org/10.1111/j.1360-0443.2012.03889.x
96. van der Meer RM, Willemsen MC, Smit F, and Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database of Systematic Reviews, 2006; 3:CD006102. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006102/abstract
97. Cooper J, Borland R, McKee SA, Yong HH, and Dugue PA. Depression motivates quit attempts but predicts relapse: Differential findings for gender from the International Tobacco Control Study. Addiction, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26888199
98. Morozova M, Rabin RA, and George TP. Co-morbid tobacco use disorder and depression: A re-evaluation of smoking cessation therapy in depressed smokers. American Journal on Addictions, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26354720
99. Secades-Villa R, Gonzalez-Roz A, Garcia-Perez A, and Becona E. Psychological, pharmacological, and combined smoking cessation interventions for smokers with current depression: A systematic review and meta-analysis. PLoS ONE, 2017; 12(12):e0188849. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29206852
100. Gierisch J, Bastian L, Calhoun P, McDuffie J, Williams J, et al. Comparative effectiveness of smoking cessation treatments for patients with depression: A systematic review and meta-analysis of the evidence, Department of Veterans Affairs, Veterans Health Administration, and Health Services Research & Development Service, Editors. 2010. Available from: http://www.ncbi.nlm.nih.gov/books/NBK51226/pdf/TOC.pdf .
101. Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depressiona randomized trial. Annals of Internal Medicine, 2013; 159(6):390–400. Available from: http://dx.doi.org/10.7326/0003-4819-159-6-201309170-00005
102. Piper ME, Cook JW, Schlam TR, Jorenby DE, and Baker TB. Anxiety diagnoses in smokers seeking cessation treatment: Relations with tobacco dependence, withdrawal, outcome, and response to treatment. Addiction, 2011; 106(2):418–27. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017215/
103. Kimbrel NA, Morissette SB, Gulliver SB, Langdon KJ, and Zvolensky MJ. The effect of social anxiety on urge and craving among smokers with and without anxiety disorders. Drug and Alcohol Dependence, 2014; 135:59–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24331637
104. Willcutt EG. The prevalence of DSM-iv attention-deficit/hyperactivity disorder: A meta-analytic review. Neurotherapeutics, 2012; 9(3):490–9. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441936/
105. Schoenfelder EN, Faraone SV, and Kollins SH. Stimulant treatment of ADHD and cigarette smoking: A meta-analysis. Pediatrics, 2014; 133(6):1070–80. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24819571
106. McClernon FJ and Kollins SH. ADHD and smoking: From genes to brain to behavior. Annals of the New York Academy of Sciences, 2008; 1141:131–47. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2758663/
107. Lee SS, Humphreys KL, Flory K, Liu R, and Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: A meta-analytic review. Clinical Psychology Review, 2011; 31(3):328–41. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180912/
108. US Department of Health and Human Services. The health consequences of smoking: A report of the Surgeon General. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004. Available from: http://www.cdc.gov/tobacco/data_statistics/sgr/index.htm .
109. van Amsterdam J, van der Velde B, Schulte M, and van den Brink W. Causal factors of increased smoking in ADHD: A systematic review. Substance Use and Misuse, 2017:1–14. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29039714
110. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry, 2001; 158(2):282–8. Available from: http://ajp.psychiatryonline.org/doi/abs/10.1176/appi.ajp.158.2.282
111. Kollins S, McClernon F, and Van Voorhees E. Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD). Experimental and Clinical Psychopharmacology, 2010; 18(3):221–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20545386
112. Baker A, Ivers RG, Bowman J, Butler T, Kay-Lambkin FJ, et al. Where there's smoke, there's fire: High prevalence of smoking among some sub-populations and recommendations for intervention. Drug and Alcohol Review, 2006; 25(1):85–96. Available from: http://dx.doi.org/10.1080/09595230500459552
113. Guydish J, Passalacqua E, Pagano A, Martinez C, Le T, et al. An international systematic review of smoking prevalence in addiction treatment. Addiction, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26392127
114. Hurt RD, Offord KP, Croghan IT, GomezDahl L, Kottke TE, et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. Journal of the American Medical Association, 1996; 275(14):1097–103. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8601929
115. Weinberger AH, Funk AP, and Goodwin RD. A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders. Preventive Medicine, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27196143
116. Bien T and Burge R. Smoking and drinking: A review of the literature. International Journal of Addiction, 1990; 25(12):1429–54. Available from: http://www.informaworld.com/smpp/content~content=a786595399~db=all
117. Hashibe M, Straif K, Tashkin D, Morgenstern H, Greenland S, et al. Epidemiological review of marijuana use and cancer risk. Alcohol, 2005; 35(3):265–75.
118. Ashton C. Adverse effects of cannabis and cannabinoids. British Journal of Anaesthesia, 1999; 83(4):637–49. Available from: http://bja.oxfordjournals.org/cgi/content/citation/83/4/637
119. Kalant H. Adverse effects of cannabis on health: An update of the literature since 1996. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2004; 28(849−63).
120. Baker A, Ivers R, Bowman J, Butler T, Kay-Lambkin F, et al. Where there's smoke, there's fire: High prevalence of smoking among some sub-populations and recommendations for intervention. Drug and Alcohol Review, 2006; 25:85–96. Available from: http://www.informaworld.com/smpp/content~content=a741424195~db=all~order=page
121. Degenhardt L and Hall W. Patterns of co-morbidity between alcohol use and other substance use in the Australian population. Drug and Alcohol Review, 2003; 22(1):7–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12745353
122. Reichler H, Baker A, Lewin T, and Carr V. Smoking among in-patients with drug-related problems in an Australian psychiatric hospital. Drug and Alcohol Review, 2001; 20(2):231–7. Available from: http://www.informaworld.com/smpp/content~content=a713659508~db=all~order=page
123. Guydish J, Passalacqua E, Tajima B, Chan M, Chun J, et al. Smoking prevalence in addiction treatment: A review. Nicotine & Tobacco Research, 2011; 13(6):401–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21464202
124. Guydish J, Passalacqua E, Tajima B, and Manser ST. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: A review. Journal of Psychoactive Drugs, 2007; 39(4):423–33. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993183/
125. Fuller BE, Guydish J, Tsoh J, Reid MS, Resnick M, et al. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. Journal of Substance Abuse Treatment, 2007; 32(1):53–60. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496385/
126. Gentry S, Craig J, Holland R, and Notley C. Smoking cessation for substance misusers: A systematic review of qualitative studies on participant and provider beliefs and perceptions. Drug and Alcohol Dependence, 2017; 180:178–92. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28910690
127. Rothrauff T and Eby L. Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. American Journal on Addictions, 2011; 20(1):56–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21175921
128. Rothrauff T and Eby L. Substance abuse counselors' implementation of tobacco cessation guidelines. Journal of Psychoactive Drugs, 2011; 43(1):6–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21615002
129. Walsh R, Bowman J, Tzelepis F, and Lecathelinais C. Smoking cessation interventions in Australian drug treatment agencies: A national survey of attitudes and practices. Drug and Alcohol Review, 2005; 24(3):235–44. Available from: http://www.informaworld.com/smpp/content~db=all?content=10.1080/09595230500170282
130. Shu C and Le Cook B. Examining the association between substance use disorder treatment and smoking cessation. Addiction, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25683883
131. Walsh R, Bowman J, Tzelepis F, and Lecathelinais C. Regulation of environmental tobacco smoke by Australian drug treatment agencies. Australian and New Zealand Journal of Public Health, 2005; 29(3):276–8. Available from: http://www3.interscience.wiley.com/journal/118740098/abstract
132. Baca C and Yahne C. Smoking cessation during substance abuse treatment: What you need to know. Journal of Substance Abuse Treatment, 2008; 36(2):205–19. Available from: http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(08)00097-4/abstract
133. Cookson C, Strang J, Ratschen E, Sutherland G, Finch E, et al. Smoking and its treatment in addiction services: Clients' and staff behaviour and attitudes. BMC Health Services Research, 2014; 14:304. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25017205
134. Toussaint DW, VanDeMark NR, Silverstein M, and Stone E. Exploring factors related to readiness to change tobacco use for clients in substance abuse treatment. Journal of Drug Issues, 2009; 39(2). Available from: http://www.encyclopedia.com/doc/1P3-1826120721.html
135. Stuyt EB. Enforced abstinence from tobacco during in-patient dual-diagnosis treatment improves substance abuse treatment outcomes in smokers. American Journal on Addictions, 2015; 24(3):252–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25907814
136. Zawertailo LA, Baliunas D, Ivanova A, and Selby PL. Individualized treatment for tobacco dependence in addictions treatment settings: The role of current depressive symptoms on outcomes at 3 and 6 months. Nicotine & Tobacco Research, 2015; 17(8):937–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26180218
137. Winhusen TM, Kropp F, Theobald J, and Lewis DF. Achieving smoking abstinence is associated with decreased cocaine use in cocaine-dependent patients receiving smoking-cessation treatment. Drug and Alcohol Dependence, 2014; 134:391–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24128381
138. Winhusen TM, Brigham GS, Kropp F, Lindblad R, Gardin JG, 2nd, et al. A randomized trial of concurrent smoking-cessation and substance use disorder treatment in stimulant-dependent smokers. Journal of Clinical Psychiatry, 2014; 75(4):336–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24345356
139. McKelvey K, Thrul J, and Ramo D. Impact of quitting smoking and smoking cessation treatment on substance use outcomes: An updated and narrative review. Addictive Behaviors, 2017; 65:161–70. Available from: https://www.ncbi.nlm.nih.gov/pubmed/27816663
140. Martinez C, Guydish J, Le T, Tajima B, and Passalacqua E. Predictors of quit attempts among smokers enrolled in substance abuse treatment. Addictive Behaviors, 2014; 40C:1–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25218064
141. McPherson S, Orr M, Lederhos C, McDonell M, Leickly E, et al. Decreases in smoking during treatment for methamphetamine-use disorders: Preliminary evidence. Behavioural Pharmacology, 2017. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29035917
142. Thurgood SL, McNeill A, Clark-Carter D, and Brose L. A systematic review of smoking cessation interventions for adults in substance abuse treatment or recovery. Nicotine & Tobacco Research, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26069036
143. Khara M and Okoli C. The tobacco-dependence clinic: Intensive tobacco-dependence treatment in an addiction services outpatient setting. American Journal on Addictions, 2010; 20(1):45–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21175920
144. Fucito L, Toll B, Wu R, Romano D, Tek E, et al. A preliminary investigation of varenicline for heavy drinking smokers. Psychopharmacology, 2011; 215(4):655–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21221531
145. Hurt RT, Ebbert JO, Croghan IT, Schroeder DR, Hurt RD, et al. Varenicline for tobacco-dependence treatment in alcohol-dependent smokers: A randomized controlled trial. Drug and Alcohol Dependence, 2018; 184:12–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29324248
146. O'Malley SS, Zweben A, Fucito LM, Wu R, Piepmeier ME, et al. Effect of varenicline combined with medical management on alcohol use disorder with comorbid cigarette smoking: A randomized clinical trial. JAMA Psychiatry, 2017. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29261824
147. Hays J, Hurt R, Decker P, Croghan I, Offord K, et al. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. Nicotine & Tobacco Research, 2009; 11(7):859–67. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19483180
148. Poling J, Rounsaville B, Gonsai K, Severino K, and Sofuoglu M. The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: A pilot study. American Journal on Addictions, 2010; 19(5):401–8. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1521-0391.2010.00066.x/full
149. Yee A, Hoong MC, Joyce YC, and Loh HS. Smoking cessation among methadone-maintained patients: A meta-analysis. Substance Use and Misuse, 2017:1–10. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28857640
150. Drummond MB, Astemborski J, Lambert AA, Goldberg S, Stitzer ML, et al. A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users. BMC Public Health, 2014; 14:761. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25074396
151. Rohsenow DJ, Tidey JW, Martin RA, Colby SM, Sirota AD, et al. Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatment. Journal of Substance Abuse Treatment, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25805668
152. Cooney JL, Cooper S, Grant C, Sevarino K, Krishnan-Sarin S, et al. A randomized trial of contingency management for smoking cessation during intensive outpatient alcohol treatment. Journal of Substance Abuse Treatment. Available from: http://dx.doi.org/10.1016/j.jsat.2016.07.002
153. Alessi SM, Petry NM, and Urso J. Contingency management promotes smoking reductions in residential substance abuse patients. Journal of Applied Behavior Analysis, 2008; 41(4):617–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19192865
154. Dunn K, Sigmon S, Thomas C, Heil S, and Higgins S. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: A pilot study. Journal of Applied Behavior Analysis, 2008; 41(4):527–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19192857
155. Dunn K, Sigmon S, Reimann E, Badger G, Heil S, et al. A contingency-management intervention to promote initial smoking cessation among opioid-maintained patients. Experimental and Clinical Psychopharmacology, 2010; 18(1):37–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20158293
156. Alessi SM and Petry NM. Smoking reductions and increased self-efficacy in a randomized controlled trial of smoking abstinence-contingent incentives in residential substance abuse treatment patients. Nicotine & Tobacco Research, 2014; 16(11):1436–45. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24935755
157. Rohsenow DJ, Tidey JW, Kahler CW, Martin RA, Colby SM, et al. Intolerance for withdrawal discomfort and motivation predict voucher-based smoking treatment outcomes for smokers with substance use disorders. Addictive Behaviors, 2014; 43C:18–24. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25531536
158. Rohsenow DJ, Martin RA, Monti PM, Colby SM, Day AM, et al. Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment. Journal of Substance Abuse Treatment, 2014; 46(3):346–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24210533
159. Finkelstein J, Lapshin O, and Cha E. Feasibility of promoting smoking cessation among methadone users using multimedia computer-assisted education. Journal of Medical Internet Research, 2008; 10(5):e33. Available from: http://www.jmir.org/2008/5/e33/
160. Bowman J and Walsh R. Smoking intervention within alcohol and other drug treatment services: A selective review with suggestions for practical management. Drug and Alcohol Review, 2003; 22(1):73–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12745361
161. Guydish J, Ziedonis D, Tajima B, Seward G, Passalacqua E, et al. Addressing tobacco through organizational change (ATTOC) in residential addiction treatment settings. Drug and Alcohol Dependence, 2012; 121(1–2):30–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21906892
162. Allsop S, Carter O, and Lenton S. Enhancing clinical research with alcohol, tobacco and cannabis problems and dependence. Drug and Alcohol Review, 2010; 29(5):483–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20887571
163. Fu SS, McFall M, Saxon AJ, Beckham JC, Carmody TP, et al. Post-traumatic stress disorder and smoking: A systematic review. Nicotine & Tobacco Research, 2007; 9(11):1071–84. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17978982
164. Flanagan JC, Hakes JK, McClure EA, Snead AL, and Back SE. Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample. American Journal on Addictions, 2016; 25(4):283–90. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27196699
165. McFall M, Saxon A, Malte C, Chow B, Bailey S, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: A randomized controlled trial. Journal of the American Medical Association, 2010; 304(22):2485–93. Available from: http://jama.ama-assn.org/content/304/22/2485.long
166. McFall M, Saxon AJ, Thompson CE, Yoshimoto D, Malte C, et al. Improving the rates of quitting smoking for veterans with posttraumatic stress disorder. American Journal of Psychiatry, 2005; 162(7):1311–9. Available from: http://dx.doi.org/10.1176/appi.ajp.162.7.1311
167. Barnett PG, Jeffers A, Smith MW, Chow BK, McFall M, et al. Cost-effectiveness of integrating tobacco cessation into post-traumatic stress disorder treatment. Nicotine & Tobacco Research, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25943761
168. Hertzberg MA, Moore SD, Feldman ME, and Beckham JC. A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 2001; 21(1):94–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11199956/
169. Hertzberg JS, Carpenter VL, Kirby AC, Calhoun PS, Moore SD, et al. Mobile contingency management as an adjunctive smoking cessation treatment for smokers with posttraumatic stress disorder. Nicotine & Tobacco Research, 2013; 15(11):1934–8. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790624/
170. Battaglia C, Peterson J, Whitfield E, Min SJ, Benson SL, et al. Integrating motivational interviewing into a home telehealth program for veterans with posttraumatic stress disorder who smoke: A randomized controlled trial. Journal of Clinical Psychology, 2016; 72(3):194-206. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/jclp.22252
171. Dedert EA, Resick PA, McFall ME, Dennis PA, Olsen M, et al. Pilot cases of combined cognitive processing therapy and smoking cessation for smokers with posttraumatic stress disorder. Behavior Therapy, 2016; 47(1):54–65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26763497
172. Jackson JG, Diaz FJ, Lopez L, and de Leon J. A combined analysis of worldwide studies demonstrates an association between bipolar disorder and tobacco smoking behaviors in adults. Bipolar Disorders, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26238269
173. George TP, Wu BS, and Weinberger AH. A review of smoking cessation in bipolar disorder: Implications for future research. Journal of Dual Diagnosis, 2012; 8(2):126–30. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378056/
174. Slyepchenko A, Brunoni AR, McIntyre RS, Quevedo J, and Carvalho AF. The adverse effects of smoking on health outcomes in bipolar disorder: A review and synthesis of biological mechanisms. Curr Mol Med, 2016; 16(2):187–205. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26812916
175. Thomson D, Berk M, Dodd S, Rapado-Castro M, Quirk SE, et al. Tobacco use in bipolar disorder. Clinical Psychopharmacology and Neuroscience, 2015; 13(1):1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25912533
176. Weinberger A, Vessicchio J, Sacco K, Creeden C, Chengappa K, et al. A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. Journal of Clinical Psychopharmacology, 2008; 28(5):584–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18794666
177. Wu BS, Weinberger AH, Mancuso E, Wing VC, Haji-Khamneh B, et al. A preliminary feasibility study of varenicline for smoking cessation in bipolar disorder. Journal of Dual Diagnosis, 2012; 8(2):131–2. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435104/
178. Evins AE, Cather C, Pratt SA, Pachas GN, Hoeppner SS, et al. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: A randomized clinical trial. Journal of the American Medical Association, 2014; 311(2):145–54. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124884/
179. Chengappa KN, Perkins KA, Brar JS, Schlicht PJ, Turkin SR, et al. Varenicline for smoking cessation in bipolar disorder: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry, 2014; 75(7):765–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25006684
180. McGrath JJ and Sasser ES. New directions in the epidemiology of schizophrenia. Medical Journal of Australia, 2009; 190(4):S7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19220176
181. Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C, et al. Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. Journal of Psychiatric Research, 2014; 48(1):102–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24139811
182. Williams JM and Foulds J. Successful tobacco dependence treatment in schizophrenia. American Journal of Psychiatry, 2007; 164(2):222–7; quiz 373. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17267783
183. Kelly DL, Raley HG, Lo S, Wright K, Liu F, et al. Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia. Schizophrenia Bulletin, 2012; 38(3):543–51. Available from: http://schizophreniabulletin.oxfordjournals.org/content/38/3/543.abstract
184. Williams JM and Ziedonis DM. Snuffing out tobacco dependence. Behavioral Healthcare, 2006; 26(5):27–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16736916
185. Tsoi DT, Porwal M, and Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews, 2013; 2:Cd007253. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23450574
186. Baker A, Richmond R, Lewin T, and Kay-Lambkin F. Cigarette smoking and psychosis: Naturalistic follow up 4 years after an intervention trial. The Australian and New Zealand Journal of Psychiatry, 2010; 44(4):342–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20307166
187. Miyauchi M, Kishida I, Suda A, Shiraishi Y, Fujibayashi M, et al. Long term effects of smoking cessation in hospitalized schizophrenia patients. BMC Psychiatry, 2017; 17(1):87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28270120
188. Kishi T and Iwata N. Varenicline for smoking cessation in people with schizophrenia: Systematic review and meta-analysis. European Archives of Psychiatry and Clinical Neuroscience, 2015; 265(3):259–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25283510
189. Stubbs B, Vancampfort D, Bobes J, De Hert M, and Mitchell AJ. How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview. Acta Psychiatrica Scandinavica, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25754402
190. Evins AE and Cather C. Effective cessation strategies for smokers with schizophrenia. Int Rev Neurobiol, 2015; 124:133–47. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26472528
191. US Food and Drug Administration (FDA). Joint meeting of the psychopharmacologic drugs advisory committee and drug safety and risk management advisory committee. 2016. Available from: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PsychopharmacologicDrugsAdvisoryCommittee/UCM520103.pdf
192. Jeon DW, Shim JC, Kong BG, Moon JJ, Seo YS, et al. Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial. Schizophrenia Research, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27543252
193. Smith RC, Amiaz R, Si TM, Maayan L, Jin H, et al. Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: A double-blind randomized trial. PLoS ONE, 2016; 11(1):e0143490. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26730716
194. Wu Q, Gilbody S, Peckham E, Brabyn S, and Parrott S. Varenicline for smoking cessation and reduction in people with severe mental illnesses: Systematic review and meta-analysis. Addiction, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27043328
195. Cather C, Pachas GN, Cieslak KM, and Evins AE. Achieving smoking cessation in individuals with schizophrenia: Special considerations. CNS Drugs, 2017; 31(6):471–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28550660
196. [No authors listed]. For the patient. Do African American teens have equal access to nicotine patch and gum? Ethnicity & Disease, 2010; 20(2):195. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20503903
197. The crisis in correctional health care: The impact of the national drug control strategy on correctional health services. American college of physicians, national commission on correctional health care, and American correctional health services association. Annals of Internal Medicine, 1992; 117(1):71–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1596049
198. Skelton E, Tzelepis F, Shakeshaft A, Guillaumier A, Dunlop A, et al. Smoking cessation care provision in Australian alcohol and other drug treatment services: A cross-sectional survey of staff self-reported practices. Journal of Substance Abuse Treatment, 2017; 77:101–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28476261
199. Sharma R, Meurk C, Bell S, Ford P, and Gartner C. Australian mental health care practitioners' practices and attitudes for encouraging smoking cessation and tobacco harm reduction in smokers with severe mental illness. International Journal of Mental Health Nursing, 2017. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28160384
200. Abrantes A, Strong D, Lloyd-Richardson E, Niaura R, Kahler C, et al. Regular exercise as a protective factor in relapse following smoking cessation treatment. American Journal on Addictions, 2009; 18(1):100–1. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19219672
201. Ratschen E, Britton J, Doody GA, Leonardi-Bee J, and McNeill A. Tobacco dependence, treatment and smoke-free policies: A survey of mental health professionals' knowledge and attitudes. General Hospital Psychiatry, 2009; 31(6):576–82. Available from: http://www.sciencedirect.com/science/journal/01638343
202. Skelton E, Tzelepis F, Shakeshaft A, Guillaumier A, Dunlop A, et al. Addressing tobacco in Australian alcohol and other drug treatment settings: A cross-sectional survey of staff attitudes and perceived barriers. Substance Abuse Treatment, Prevention, and Policy, 2017; 12(1):20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28464898
203. Wye P, Bowman J, Wiggers J, Baker A, Carr V, et al. Providing nicotine dependence treatment to psychiatric inpatients: The views of Australian nurse managers. Journal of Psychiatric and Mental Health Nursing, 2010; 17(4):319–27. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20529182
204. Knudsen HK. Implementation of smoking cessation treatment in substance use disorder treatment settings: A review. American Journal of Drug and Alcohol Abuse, 2016:1–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27314884
205. Pagano A, Tajima B, and Guydish J. Barriers and facilitators to tobacco cessation in a nationwide sample of addiction treatment programs. Journal of Substance Abuse Treatment, 2016; 67:22–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27296658
206. Sheals K, Tombor I, McNeill A, and Shahab L. A mixed-method systematic review and meta-analysis of mental health professionals' attitudes toward smoking and smoking cessation amongst people with mental illnesses. Addiction, 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27003925
207. Johnson J, Malchy L, Ratner P, Hossain S, Procyshyn R, et al. Community mental healthcare providers' attitudes and practices related to smoking cessation interventions for people living with severe mental illness. Patient Education and Counseling, 2009; 77(2):289–95. Available from: http://www.pec-journal.com/article/PIIS0738399109000858/fulltext
208. Schwindt RG, McNelis AM, and Sharp D. Evaluation of a theory-based education program to motivate nursing students to intervene with their seriously mentally ill clients who use tobacco. Archives of Psychiatric Nursing, 2014; 28(4):277–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25017562
209. Williams JM, Stroup TS, Brunette MF, and Raney LE. Integrated care: Tobacco use and mental illness: A wake-up call for psychiatrists. Psychiatric Services, 2014. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25270381
210. Cerimele JM, Halperin AC, and Saxon AJ. Tobacco use treatment in primary care patients with psychiatric illness. Journal of the American Board of Family Medicine, 2014; 27(3):399–410. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24808119
211. Mitchell AJ, Vancampfort D, De Hert M, and Stubbs B. Do people with mental illness receive adequate smoking cessation advice? A systematic review and meta-analysis. General Hospital Psychiatry, 2015; 37(1):14–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25510845
212. Shi Y. Smoking cessation among people seeking mental health treatment. Psychiatric Services, 2014; 65(7):957–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26037007
213. Rogers E and Sherman S. Tobacco use screening and treatment by outpatient psychiatrists before and after release of the American psychiatric association treatment guidelines for nicotine dependence. American Journal of Public Health, 2014; 104(1):90–5. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/24228666
214. [No authors listed]. An official position statement of the association of women’s health, obstetric & neonatal nursing. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 2010; 39(5):611–3. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1552-6909.2010.01178.x/full
215. Quit Victoria. Mental health settings. 2016. Available from: http://www.quit.org.au/resource-centre/communities/mental-health-settings
216. Adams C, Baillie L, and Copeland A. The smoking-related weight and eating episodes test (sweet): Development and preliminary validation. Nicotine & Tobacco Research, 2011; 13(11):1123–31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21849410
217. Ashton M. Policy within mental health services: Pro-actively addressing tobacco. The Mental Health Service Conference, 2005.
218. Wye P, Bowman J, Wiggers J, Baker A, Carr V, et al. An audit of the prevalence of recorded nicotine dependence treatment in an Australian psychiatric hospital. Australian and New Zealand Journal of Public Health, 2010; 34(3):298–303. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20618273
219. Wye P, Bowman J, Wiggers J, Baker A, Knight J, et al. Smoking restrictions and treatment for smoking: Policies and procedures in psychiatric inpatient units in Australia Psychiatric Services (Washington, D.C.), 2009; 60(1):100–7. Available from: http://ps.psychiatryonline.org/cgi/content/full/60/1/100
220. Abrams D, Graham A, Levy D, Mabry P, and Orleans C. Boosting population quits through evidence-based cessation treatment and policy. American Journal of Preventive Medicine, 2010; 38(3 suppl.):S351–63. Available from: http://www.ajpm-online.net/article/PIIS0749379709008939/fulltext
221. Shmueli D, Fletcher L, Hall S, Hall S, and Prochaska J. Changes in psychiatric patients' thoughts about quitting smoking during a smoke-free hospitalization. Nicotine & Tobacco Research, 2008; 10(5):875–81. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18569762
222. Keizer I, Descloux V, and Eytan A. Variations in smoking after admission to psychiatric inpatient units and impact of a partial smoking ban on smoking and on smoking-related perceptions. International Journal of Social Psychiatry, 2009; 55(2):109–23. Available from: http://isp.sagepub.com/cgi/reprint/55/2/109
223. Stockings EA, Bowman JA, Prochaska JJ, Baker AL, Clancy R, et al. The impact of a smoke-free psychiatric hospitalization on patient smoking outcomes: A systematic review. Australian and New Zealand Journal of Psychiatry, 2014; 48(7):617–33. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24819934
224. Leyro TM, Hall SM, Hickman N, Kim R, Hall SE, et al. Clinical management of tobacco dependence in inpatient psychiatry: Provider practices and patient utilization. Psychiatric Services, 2013; 64(11):1161–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24185538
225. Prochaska JJ, Fletcher L, Hall SE, and Hall SM. Return to smoking following a smoke-free psychiatric hospitalization. American Journal on Addictions, 2006; 15(1):15–22. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16449089
226. Vorspan F, Bloch V, Guillem E, Dupuy G, Pirnay S, et al. Smoking ban in a psychiatry department: Are nonsmoking employees less exposed to environmental tobacco smoke? European Psychiatry, 2009; 24(8):529–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19540729
227. Stockings EA, Bowman JA, Bartlem KM, McElwaine KM, Baker AL, et al. Implementation of a smoke-free policy in an inpatient psychiatric facility: Patient-reported adherence, support, and receipt of nicotine-dependence treatment. International Journal of Mental Health Nursing, 2015. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25970237
228. Filia SL, Gurvich CT, Horvat A, Shelton CL, Katona LJ, et al. Inpatient views and experiences before and after implementing a totally smoke-free policy in the acute psychiatry hospital setting. International Journal of Mental Health Nursing, 2015; 24(4):350–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26189488
229. Magor-Blatch LE and Rugendyke AR. Going smoke-free: Attitudes of mental health professionals to policy change. Journal of Psychiatric and Mental Health Nursing, 2016; 23(5):290–302. Available from: h ttp://www.ncbi.nlm.nih.gov/pubmed/27278902
230. Oliveira RM and Furegato AR. The decreasing number of cigarettes during psychiatric hospitalization: Intervention or punishment? Revista Brasileira de Enfermagem, 2015; 68(1):76–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25946498
231. Chapman S. A complete smoking ban in psychiatric hospitals is ethically wrong. British Medical Journal, 2015; 351:h6288. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26607749
232. Arnott D, Wessely S, and Fitzpatrick M. Should psychiatric hospitals completely ban smoking? British Medical Journal, 2015; 351:h5654. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26536887